Cushionflor Sheet Vinyl by Congoleum Corporation

Congoleum Corporation’s Cushionflor sheet vinyl, produced between 1978 and 1980, is among the flooring products documented in connection with asbestos exposure claims filed through the Congoleum Asbestos PI Trust. This article provides a factual overview of the product, its asbestos content, the circumstances under which workers were exposed, and the legal options available to individuals who handled or worked around this material.

Product Description

Cushionflor was a resilient sheet vinyl flooring product manufactured by Congoleum Corporation, a company with deep roots in the American floor covering industry. Unlike individual floor tiles, sheet vinyl products like Cushionflor were produced in continuous rolls and installed across large surface areas in residential, commercial, and industrial settings. The product’s name reflected one of its key selling points: a cushioned, layered construction designed to provide underfoot comfort and durability.

Congoleum marketed Cushionflor as a practical, cost-effective flooring solution during the late 1970s. At the time, resilient flooring products routinely incorporated asbestos fibers into their composition, a widespread industry practice that manufacturers relied on for reinforcement, dimensional stability, and fire resistance. Cushionflor fit within this broader category of asbestos-containing resilient flooring that was common in American construction during the mid-twentieth century and into the 1970s.

Congoleum Corporation ultimately filed for bankruptcy reorganization in part due to mounting asbestos liability, which led to the establishment of the Congoleum Asbestos PI Trust to compensate individuals harmed by exposure to the company’s asbestos-containing products, including Cushionflor sheet vinyl.

Asbestos Content

Cushionflor sheet vinyl, as produced by Congoleum Corporation during the 1978–1980 period, contained asbestos fibers incorporated into its layered construction. Resilient sheet vinyl flooring of this era typically used asbestos in the backing, felt underlayer, or reinforcing layers of the product. These fibers were bound within the material under normal, undisturbed conditions but could be released when the product was cut, trimmed, sanded, scraped, or otherwise disturbed during installation, renovation, or removal.

The presence of asbestos in resilient flooring products from this period is recognized under the Asbestos Hazard Emergency Response Act (AHERA) framework, which classifies certain flooring materials as asbestos-containing building materials (ACBMs) subject to inspection and proper management requirements. Regulatory guidance from OSHA and the Environmental Protection Agency has long recognized that cutting or abrading asbestos-containing resilient flooring can generate respirable asbestos fibers at levels that present a health hazard.

The Congoleum Asbestos PI Trust’s acceptance of claims related to Cushionflor is itself a documented acknowledgment that this product is associated with asbestos-related injury claims.

How Workers Were Exposed

Workers exposed to Cushionflor sheet vinyl fell primarily into the category of industrial workers and general laborers who handled, installed, maintained, or removed the product during its service life. Exposure scenarios were not limited to the original installation period; asbestos-containing resilient flooring remained in place for years or decades after installation, and renovation and demolition activities represented ongoing exposure opportunities long after manufacturing ceased.

Documented exposure pathways for workers involved with asbestos-containing sheet vinyl products like Cushionflor include:

  • Cutting and trimming during installation: Sheet vinyl must be measured and cut to fit a space, a process that required scoring or cutting through the full thickness of the product, including any asbestos-containing layers. This generated dust and fiber release at the point of cutting.

  • Sanding and surface preparation: When existing flooring was prepared for new material or when subfloor leveling was required, power or hand sanding of asbestos-containing sheet vinyl could release significant quantities of airborne fibers.

  • Scraping and removal: Removal of old sheet vinyl, particularly when the product had been adhered with mastic, often required mechanical scraping. This process is recognized as one of the higher-risk activities associated with asbestos-containing resilient flooring.

  • Grinding and abrading: Industrial settings where flooring was subject to heavy traffic, equipment, or maintenance grinding created repeated opportunities for fiber release over time.

  • Incidental exposure: Workers performing other tasks in areas where Cushionflor was being installed or removed could be exposed to asbestos fibers dispersed into the general work environment, even without direct contact with the product.

OSHA regulations governing asbestos in construction (29 CFR 1926.1101) and general industry (29 CFR 1910.1001) reflect the recognized hazards associated with disturbing asbestos-containing flooring materials. Workers exposed to Cushionflor during the late 1970s and in subsequent years when the installed product was disturbed may have inhaled asbestos fibers that contribute to the development of asbestos-related diseases, including mesothelioma, asbestosis, and lung cancer, often with latency periods of 20 to 50 years.

Individuals diagnosed with an asbestos-related disease who can document exposure to Cushionflor sheet vinyl manufactured by Congoleum Corporation may be eligible to file a claim with the Congoleum Asbestos PI Trust.

Trust Background: Congoleum Corporation established the Congoleum Asbestos PI Trust through its bankruptcy reorganization process. The Trust was created specifically to address the asbestos personal injury liabilities of Congoleum Corporation and to provide compensation to eligible claimants. Trust claim submissions are evaluated according to the Trust’s claims processing procedures and established criteria.

Filing Eligibility: To pursue a claim with the Congoleum Asbestos PI Trust, claimants generally must demonstrate:

  • A qualifying asbestos-related disease diagnosis (such as mesothelioma, lung cancer, asbestosis, or other recognized asbestos-related conditions)
  • Documented exposure to a Congoleum asbestos-containing product, which may include Cushionflor sheet vinyl
  • Exposure that occurred within the Trust’s defined eligibility parameters

Claim Categories: The Trust typically recognizes claim categories aligned with the severity of the asbestos-related disease, including categories for malignant conditions such as mesothelioma and lung cancer, as well as nonmalignant conditions including asbestosis and pleural disease. Specific payment amounts and processing timelines are governed by the Trust’s Distribution Procedures.

Steps to Take: Individuals who believe they were exposed to Cushionflor sheet vinyl and have received an asbestos-related diagnosis should consult with an attorney experienced in asbestos trust fund claims. Documentation of work history, product identification, and medical records will generally be required to support a claim. Exposure records, employment records, and co-worker testimony can each contribute to establishing the necessary product identification and exposure history.

The existence of the Congoleum Asbestos PI Trust provides a defined legal and financial mechanism for affected workers and their families to seek compensation without the need for active litigation against Congoleum Corporation itself.